Psoriasis in the transplant population.
Organ
Psoriasis
Review
Stem cell
Therapy
Transplant
Journal
Archives of dermatological research
ISSN: 1432-069X
Titre abrégé: Arch Dermatol Res
Pays: Germany
ID NLM: 8000462
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
received:
25
04
2022
accepted:
17
11
2022
revised:
25
10
2022
medline:
25
5
2023
pubmed:
3
12
2022
entrez:
2
12
2022
Statut:
ppublish
Résumé
Solid organ and stem cell transplants are increasingly common, and dermatologists will more frequently encounter and need to manage common skin diseases, such as psoriasis, in transplant patients. This review explores psoriasis remission and occurrence in recipients of solid organ and stem cell transplants. Hematopoietic and mesenchymal stem cell transplants may show potential for treating psoriasis in patients with leukemia or who have other medical conditions requiring stem cell transplant. The effects of solid organ transplant are less clear, partly due to limitations in the breadth of the literature. De novo psoriasis has been reported in recipients of solid organ transplants, but the reasons for this development have yet to be fully understood. Overall, the literature on this subject is limited to primarily case reports. Feasibility of studies on the subject may be a considerable barrier to further research assessing the use of transplant for treating psoriasis, but there is potential benefit from transplant for psoriasis patients. This subject should receive further exploration to fully understand these benefits.
Identifiants
pubmed: 36459192
doi: 10.1007/s00403-022-02487-0
pii: 10.1007/s00403-022-02487-0
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1109-1128Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Organ Procurement and Transplantation Network, U.S. Department of Health & Human Services. National data [Internet]. Organ Procurement and Transplantation Network, U.S. Department of Health & Human Services. https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/ . Accessed 30 Mar 2022
Niederwieser D, Baldomero H, Atsuta Y et al (2019) One and half million hematopoietic stem cell transplants (HSCT). Dissemination, trends and potential to improve activity by telemedicine from the Worldwide Network for Blood and Marrow Transplantation (WBMT). Blood 134(Supplement 1):2035. https://doi.org/10.1182/blood-2019-125232
doi: 10.1182/blood-2019-125232
Rachakonda TD, Schupp CW, Armstrong AW (2014) Psoriasis prevalence among adults in the United States. J Am Acad Dermatol 70(3):512–516. https://doi.org/10.1016/j.jaad.2013.11.013
doi: 10.1016/j.jaad.2013.11.013
pubmed: 24388724
Helmick CG, Lee-Han H, Hirsch SC et al (2014) Prevalence of psoriasis among adults in the U.S.: 2003–2006 and 2009–2010 national health and nutrition examination surveys. Am J Prev Med 47(1):37–45. https://doi.org/10.1016/j.amepre.2014.02.012
doi: 10.1016/j.amepre.2014.02.012
pubmed: 24746373
pmcid: 4653077
Armstrong AW, Read C (2020) Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 323(19):1945–1960. https://doi.org/10.1001/jama.2020.4006
doi: 10.1001/jama.2020.4006
pubmed: 32427307
Chakrabarti S, Handa SK, Bryon RJ et al (2001) Will mixed chimerism cure autoimmune diseases after a nonmyeloablative stem cell transplant? Transplantation 72(2):340–342. https://doi.org/10.1097/00007890-200107270-00032
doi: 10.1097/00007890-200107270-00032
pubmed: 11477365
Masszi T, Farkas A, Remenyi P et al (2006) Ten-year remission of psoriasis after allogeneic but not autologous bone marrow transplantation. Dermatology 212(1):88–89. https://doi.org/10.1159/000089032
doi: 10.1159/000089032
pubmed: 16319484
Cooley HM, Snowden JA, Grigg AP, Wicks IP (1997) Outcome of rheumatoid arthritis and psoriasis following autologous stem cell transplantation for hematologic malignancy. Arthritis Rheum 40(9):1712–1715. https://doi.org/10.1002/art.1780400923
doi: 10.1002/art.1780400923
pubmed: 9324027
Kojima R, Kami M, Kim SW et al (2003) Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 32(4):439–442. https://doi.org/10.1038/sj.bmt.1704146
doi: 10.1038/sj.bmt.1704146
pubmed: 12900783
Woods AC, Mant MJ (2006) Amelioration of severe psoriasis with psoriatic arthritis for 20 years after allogeneic haematopoietic stem cell transplantation. Ann Rheum Dis 65(5):697. https://doi.org/10.1136/ard.2005.039479
doi: 10.1136/ard.2005.039479
pubmed: 16611874
pmcid: 1798128
Hinterberger W, Hinterberger-Fischer M, Marmont A (2002) Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases. Bone Marrow Transplant 30(11):753–759. https://doi.org/10.1038/sj.bmt.1703686
doi: 10.1038/sj.bmt.1703686
pubmed: 12439698
Yin JA, Jowitt SN (1992) Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia. Bone Marrow Transplant 9(1):31–33
pubmed: 1543947
Slavin S, Nagler A, Varadi G, Or R (2000) Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. Exp Hematol 28(7):853–857. https://doi.org/10.1016/s0301-472x(00)00172-7
doi: 10.1016/s0301-472x(00)00172-7
pubmed: 10907647
Ranti J, Kurki S, Salmenniemi U et al (2018) Early CD8+-recovery independently predicts low probability of disease relapse but also associates with severe GVHD after allogeneic HSCT. PLoS ONE 13(9):e0204136. https://doi.org/10.1371/journal.pone.0204136
doi: 10.1371/journal.pone.0204136
pubmed: 30235281
pmcid: 6147489
He YL, Lu XJ, Qiu JY, Zhu TJ (2005) Severe vulgaris psoriatic patients with acute myelogenous leukaemia and resolution after allogeneic bone marrow transplantation/peripheral blood stem cell transplantation. Chin Med J (Engl) 118(10):861–865
pubmed: 15989770
Owczarczyk-Saczonek A, Krajewska-Włodarczyk M, Kruszewska A et al (2017) Stem cells as potential candidates for psoriasis cell-replacement therapy. Int J Mol Sci. 18(10):2182. https://doi.org/10.3390/ijms18102182
doi: 10.3390/ijms18102182
pubmed: 29053579
pmcid: 5666863
Paganelli A, Tarentini E, Benassi L et al (2020) Mesenchymal stem cells for the treatment of psoriasis: a comprehensive review. Clin Exp Dermatol 45(7):824–830. https://doi.org/10.1111/ced.14269
doi: 10.1111/ced.14269
pubmed: 32386432
Chen H, Niu JW, Ning HM et al (2016) Treatment of psoriasis with mesenchymal stem cells. Am J Med 129(3):e13–e14. https://doi.org/10.1016/j.amjmed.2015.11.001
doi: 10.1016/j.amjmed.2015.11.001
pubmed: 26582058
Wang Y, Chen X, Cao W, Shi Y (2014) Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol 15(11):1009–1016. https://doi.org/10.1038/ni.3002
doi: 10.1038/ni.3002
pubmed: 25329189
Lwin SM, Snowden JA, Griffiths CEM (2021) The promise and challenges of cell therapy for psoriasis. Br J Dermatol 185(5):887–898. https://doi.org/10.1111/bjd.20517
doi: 10.1111/bjd.20517
pubmed: 34036569
Wang SG, Hsu NC, Wang SM, Wang FN (2020) Successful treatment of plaque psoriasis with allogeneic gingival mesenchymal stem cells: a case study. Case Rep Dermatol Med 2020:4617520. https://doi.org/10.1155/2020/4617520
doi: 10.1155/2020/4617520
pubmed: 32280547
pmcid: 7142341
Ahn H, Lee SY, Jung WJ et al (2021) Psoriasis treatment using minimally manipulated umbilical cord-derived mesenchymal stem cells: a case report. World J Clin Cases 9(23):6798–6803. https://doi.org/10.12998/wjcc.v9.i23.6798
doi: 10.12998/wjcc.v9.i23.6798
pubmed: 34447827
pmcid: 8362539
Lee YS, Sah SK, Lee JH et al (2017) Human umbilical cord blood-derived mesenchymal stem cells ameliorate psoriasis-like skin inflammation in mice. Biochem Biophys Rep 9:281–288. https://doi.org/10.1016/j.bbrep.2016.10.002
doi: 10.1016/j.bbrep.2016.10.002
pubmed: 28956015
Cheng L, Wang S, Peng C et al (2022) Human umbilical cord mesenchymal stem cells for psoriasis: a phase 1/2a, single-arm study. Signal Transduct Target Ther 7(1):263. https://doi.org/10.1038/s41392-022-01059-y
doi: 10.1038/s41392-022-01059-y
pubmed: 35927231
pmcid: 9352692
Braiteh F, Hymes SR, Giralt SA, Jones R (2008) Complete remission of psoriasis after autologous hematopoietic stem-cell transplantation for multiple myeloma. J Clin Oncol 26(27):4511–4513. https://doi.org/10.1200/jco.2008.17.6560
doi: 10.1200/jco.2008.17.6560
pubmed: 18802165
De Jesus MM, Santiago JS, Trinidad CV et al (2016) Autologous adipose-derived mesenchymal stromal cells for the treatment of psoriasis vulgaris and psoriatic arthritis: a case report. Cell Transplant 25(11):2063–2069. https://doi.org/10.3727/096368916x691998
doi: 10.3727/096368916x691998
pubmed: 27301844
Daikeler T, Labopin M, Di Gioia M et al (2011) Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT autoimmune disease working party. Blood 118(6):1693–1698. https://doi.org/10.1182/blood-2011-02-336156
doi: 10.1182/blood-2011-02-336156
pubmed: 21596847
Daikeler T, Günaydin I, Einsele H et al (1999) Transmission of psoriatic arthritis by allogeneic bone marrow transplantation for chronic myelogenous leukaemia from an HLA-identical donor. Rheumatology (Oxford) 38(1):89–90. https://doi.org/10.1093/rheumatology/38.1.89
doi: 10.1093/rheumatology/38.1.89
pubmed: 10334690
Hubiche T, Leaute-Labreze C, Lepreux S et al (2007) Psoriasis after cord blood stem cell transplantation. Br J Dermatol 156(2):386–388. https://doi.org/10.1111/j.1365-2133.2006.07629.x
doi: 10.1111/j.1365-2133.2006.07629.x
pubmed: 17223889
Gardembas-Pain M, Ifrah N, Foussard C et al (1990) Psoriasis after allogeneic bone marrow transplantation. Arch Dermatol 126(11):1523. https://doi.org/10.1001/archderm.1990.01670350139033
doi: 10.1001/archderm.1990.01670350139033
pubmed: 2241215
Snowden JA, Heaton DC (1997) Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity. Br J Dermatol. 137(1):130–132
doi: 10.1046/j.1365-2133.1997.17821869.x
pubmed: 9274640
Wahie S, Alexandroff A, Reynolds NJ, Meggit SJ (2006) Psoriasis occurring after myeloablative therapy and autologous stem cell transplantation. Br J Dermatol 154(1):194–195. https://doi.org/10.1111/j.1365-2133.2005.07026.x
doi: 10.1111/j.1365-2133.2005.07026.x
pubmed: 16729392
Mehta K, Jaiswal P, Briggs F et al (2018) In-patient outcomes of hematopoietic stem cell transplantation in patients with immune mediated inflammatory diseases: a nationwide study. Sci Rep 8(1):6825. https://doi.org/10.1038/s41598-018-24060-4
doi: 10.1038/s41598-018-24060-4
pubmed: 29717163
pmcid: 5931606
Kawakami Y, Oyama N, Nakamura K et al (2007) Psoriasiform eruption associated with graft-versus-host disease. Acta Derm Venereol 87(5):436–438. https://doi.org/10.2340/00015555-0274
doi: 10.2340/00015555-0274
pubmed: 17721657
Matsushita T, Hasegawa M, Shirasaki F et al (2008) A case of acute cutaneous graft-versus-host disease mimicking psoriasis vulgaris. Dermatology 216(1):64–67. https://doi.org/10.1159/000109361
doi: 10.1159/000109361
pubmed: 18032902
Vernali S, Vertes George E, Gonzalez Santiago T, Motaparthi K (2018) Psoriasiform graft-versus-host disease: report and brief review of the literature. Am J Dermatopathol 40(7):511–514. https://doi.org/10.1097/dad.0000000000001078
doi: 10.1097/dad.0000000000001078
pubmed: 29293122
Zhou L, Du GS, Pan LC et al (2017) Sirolimus treatment for cirrhosis or hepatocellular carcinoma patients accompanied by psoriasis after liver transplantation: a single center experience. Oncol Lett 14(6):7817–7824. https://doi.org/10.3892/ol.2017.7217
doi: 10.3892/ol.2017.7217
pubmed: 29344227
pmcid: 5755223
Foroncewicz B, Mucha K, Lerut J et al (2014) Cyclosporine is superior to tacrolimus in liver transplant recipients with recurrent psoriasis. Ann Transplant 19:427–433. https://doi.org/10.12659/aot.890754
doi: 10.12659/aot.890754
pubmed: 25163829
Meneghini M, Gómez C, Mast R et al (2017) Complete regression of psoriatic arthritis after belatacept conversion in a highly HLA-sensitized kidney transplant patient. Am J Transplant 17(5):1409–1413. https://doi.org/10.1111/ajt.14172
doi: 10.1111/ajt.14172
pubmed: 27996207
Sheu J, Saavedra AP, Degar BA et al (2015) Bone marrow engraftment and associated dermatologic sequelae in a three-yr-old after liver transplantation. Pediatr Transplant 19(2):E41–E46. https://doi.org/10.1111/petr.12412
doi: 10.1111/petr.12412
pubmed: 25516432
Ville S, Cantarovich D (2018) Belatacept and autoimmune adverse events. Transplantation 102(7):e355–e356. https://doi.org/10.1097/tp.0000000000002247
doi: 10.1097/tp.0000000000002247
pubmed: 29672443
pmcid: 7228644
Levitsky J, Miller J, Huang X et al (2013) Inhibitory effects of belatacept on allospecific regulatory T-cell generation in humans. Transplantation 96(8):689–696. https://doi.org/10.1097/TP.0b013e31829f1607
doi: 10.1097/TP.0b013e31829f1607
pubmed: 23883971
pmcid: 3800494
Prussick R, Wu JJ, Armstrong AW et al (2018) Psoriasis in solid organ transplant patients: best practice recommendations from The Medical Board of the National Psoriasis Foundation. J Dermatol Treat 29(4):329–333. https://doi.org/10.1080/09546634.2017.1373737
doi: 10.1080/09546634.2017.1373737
Eedy DJ, Burrows D, Bridges JM, Jones FG (1990) Clearance of severe psoriasis after allogenic bone marrow transplantation. BMJ 300(6729):908. https://doi.org/10.1136/bmj.300.6729.908
doi: 10.1136/bmj.300.6729.908
pubmed: 2337714
pmcid: 1662650
Jowitt SN, Yin JA (1990) Psoriasis and bone marrow transplantation. BMJ 300(6736):1398–1399. https://doi.org/10.1136/bmj.300.6736.1398-c
doi: 10.1136/bmj.300.6736.1398-c
pubmed: 2372592
pmcid: 1662984
Yokota A, Hukazawa M, Nakaseko C et al (1996) [Resolution of psoriasis vulgaris following allogeneic bone marrow transplantation for aplastic anemia]. Rinsho Ketsueki. 37(1):35–39
pubmed: 8683865
Kishimoto Y, Yamamoto Y, Ito T et al (1997) Transfer of autoimmune thyroiditis and resolution of palmoplantar pustular psoriasis following allogeneic bone marrow transplantation. Bone Marrow Transplant 19(10):1041–1043. https://doi.org/10.1038/sj.bmt.1700789
doi: 10.1038/sj.bmt.1700789
pubmed: 9169651
Snowden JA, Kearney P, Kearney A et al (1998) Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation. Arthritis Rheum 41(3):453–459. https://doi.org/10.1002/1529-0131(199803)41:3%3c453::Aid-art11%3e3.0.Co;2-#
doi: 10.1002/1529-0131(199803)41:3<453::Aid-art11>3.0.Co;2-#
pubmed: 9506573
Adkins DR, Abidi MH, Brown RA et al (2000) Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy. Bone Marrow Transplant 26(11):1239–1241. https://doi.org/10.1038/sj.bmt.1702703
doi: 10.1038/sj.bmt.1702703
pubmed: 11149740
Kanamori H, Tanaka M, Kawaguchi H et al (2002) Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature. Am J Hematol 71(1):41–44. https://doi.org/10.1002/ajh.10169
doi: 10.1002/ajh.10169
pubmed: 12221673
Windrum P, Jones FG, McMullin MF (2004) Adoptive immunotherapy after bone marrow transplantation in a patient with relapsed acute myeloid leukaemia and severe psoriasis. Bone Marrow Transplant 34(3):281–282. https://doi.org/10.1038/sj.bmt.1704558
doi: 10.1038/sj.bmt.1704558
pubmed: 15156169
Mori J, Kakihana K, Ohashi K (2012) Sustained remission of psoriasis vulgaris after allogeneic bone marrow transplantation. Br J Haematol 159(2):121. https://doi.org/10.1111/bjh.12026
doi: 10.1111/bjh.12026
pubmed: 22924739
Kaffenberger BH, Wong HK, Jarjour W, Andritsos LA (2013) Remission of psoriasis after allogeneic, but not autologous, hematopoietic stem-cell transplantation. J Am Acad Dermatol 68(3):489–492. https://doi.org/10.1016/j.jaad.2012.08.021
doi: 10.1016/j.jaad.2012.08.021
pubmed: 22981608
Ciurea SO, Hansrivijit P, Ciurea AM et al (2019) Curative potential of hematopoietic stem cell transplantation for advanced psoriasis. Am J Hematol 94(6):E176–E180. https://doi.org/10.1002/ajh.25470
doi: 10.1002/ajh.25470
pubmed: 30900768
Mohren M, Daikeler T, Benz D et al (2004) Myeloablative immunosuppressive treatment with autologous haematopoietic stem cell transplantation in a patient with psoriatic arthropathy and monoclonal gammopathy of undetermined significance. Ann Rheum Dis 63(4):466–467. https://doi.org/10.1136/ard.2003.010702
doi: 10.1136/ard.2003.010702
pubmed: 15020351
pmcid: 1754961
Held K, Rahmetulla R, Loew TW, Radhi MA (2012) Complete resolution of guttate psoriasis following autologous SCT for Ewing’s sarcoma in a pediatric patient. Bone Marrow Transplant 47(12):1585–1586. https://doi.org/10.1038/bmt.2012.68
doi: 10.1038/bmt.2012.68
pubmed: 22522571
Sung SM, Kimball AB (2015) Remission of psoriasis 13 years after autologous stem cell transplant. Cutis 95(6):E7–E8
pubmed: 26125223
Azevedo A, Gonçalves C, Selores M, Torres T (2017) Remission of psoriasis after autologous stem cell transplantation—until when? Eur J Dermatol 27(1):74–75. https://doi.org/10.1684/ejd.2016.2893
doi: 10.1684/ejd.2016.2893
pubmed: 27748257
Kaloyannidis P, Al Shaibani E, Mashhour M et al (2018) De novo psoriasis vulgaris diagnosed after nivolumab treatment for refractory Hodgkin’s lymphoma, completely resolved after autologous hematopoietic stem cell transplantation. Case Rep Hematol 2018:6215958. https://doi.org/10.1155/2018/6215958
doi: 10.1155/2018/6215958
pubmed: 30410803
pmcid: 6206568
Chen W, Ren G, Zuo K, Huang X (2018) Complete remission of both immunoglobulin light chain amyloidosis and psoriasis after autologous hematopoietic stem cell transplantation: a case report. Medicine (Baltimore) 97(50):e13589. https://doi.org/10.1097/md.0000000000013589
doi: 10.1097/md.0000000000013589
pubmed: 30558027
Ugur MC, Gediz F (2021) Evaluation of patients diagnosed with psoriasis and multiple myeloma after autologous stem cell transplantation. Transfus Apher Sci 60(4):103137. https://doi.org/10.1016/j.transci.2021.103137
doi: 10.1016/j.transci.2021.103137
pubmed: 33858753
Mabuchi T, Kojima T, Yamaoka H et al (2012) Development of psoriasis 10 years after allogeneic hematopoietic cell transplantation from non-psoriatic donor: further evidences for genetics and immunopathogenesis of psoriasis. J Dermatol 39(12):1072–1074. https://doi.org/10.1111/j.1346-8138.2012.01586.x
doi: 10.1111/j.1346-8138.2012.01586.x
pubmed: 22671141
George L, Mathews V, George B et al (2015) Generalized pustular psoriasis following allogeneic stem cell transplantation. Clin Exp Dermatol 40(2):160–162. https://doi.org/10.1111/ced.12508
doi: 10.1111/ced.12508
pubmed: 25472781
Li X, Li J, Wang L et al (2015) Transmission of psoriasis by allogeneic bone marrow transplantation and blood transfusion. Blood Cancer J 5(3):e288. https://doi.org/10.1038/bcj.2015.15
doi: 10.1038/bcj.2015.15
pubmed: 25768402
pmcid: 4382657
Huang JT, Song JS, Hawryluk EB et al (2018) Nonmalignant late cutaneous changes after allogeneic hematopoietic stem cell transplant in children. J Am Acad Dermatol 79(2):230–237. https://doi.org/10.1016/j.jaad.2018.03.029
doi: 10.1016/j.jaad.2018.03.029
pubmed: 29588248
Terui H, Yamasaki K, Hagiwara-Takita A et al (2021) Pediatric psoriasis induced by HLA-B46-Cw1 haplotype: a retrospective study of psoriasis onset after hematopoietic stem cell transplantation. J Dermatol 48(9):1381–1385. https://doi.org/10.1111/1346-8138.15953
doi: 10.1111/1346-8138.15953
pubmed: 33960525
Coulson IH, Evans CD, Holden CA (1988) Generalized pustular psoriasis after renal transplantation–failure to suppress with cyclosporin A. Clin Exp Dermatol 13(6):416–417. https://doi.org/10.1111/j.1365-2230.1988.tb00741.x
doi: 10.1111/j.1365-2230.1988.tb00741.x
pubmed: 3076855
Formicone F, Fargnoli MC, Pisani F et al (2005) Cutaneous manifestations in Italian kidney transplant recipients. Transplant Proc 37(6):2527–2528. https://doi.org/10.1016/j.transproceed.2005.06.067
doi: 10.1016/j.transproceed.2005.06.067
pubmed: 16182734
Kaaroud H, Béji S, Jebali A et al (2007) Pustular psoriasis after renal transplantation. Transplant Proc 39(4):1130–1131. https://doi.org/10.1016/j.transproceed.2007.02.033
doi: 10.1016/j.transproceed.2007.02.033
pubmed: 17524911
Hoover WD (2007) Etanercept therapy for severe plaque psoriasis in a patient who underwent a liver transplant. Cutis 80(3):211–214
pubmed: 17956009
Collazo MH, González JR, Torres EA (2008) Etanercept therapy for psoriasis in a patient with concomitant hepatitis C and liver transplant. P R Health Sci J 27(4):346–347
pubmed: 19069362
Brokalaki EI, Voshege N, Witzke O et al (2012) Treatment of severe psoriasis with etanercept in a pancreas–kidney transplant recipient. Transplant Proc 44(9):2776–2777. https://doi.org/10.1016/j.transproceed.2012.09.008
doi: 10.1016/j.transproceed.2012.09.008
pubmed: 23146521
Mansouri B, Patel M, Menter A (2013) Tumour necrosis factor-α inhibitor use in patients with psoriasis with organ transplantation. Br J Dermatol 169(2):481–483. https://doi.org/10.1111/bjd.12326
doi: 10.1111/bjd.12326
pubmed: 23517414
Wei KC, Lai PC (2015) Combination of everolimus and tacrolimus: a potentially effective regimen for recalcitrant psoriasis. Dermatol Ther 28(1):25–27. https://doi.org/10.1111/dth.12176
doi: 10.1111/dth.12176
pubmed: 25285355
Madankumar R, Teperman LW, Stein JA (2015) Use of etanercept for psoriasis in a liver transplant recipient. JAAD Case Rep 1(6):S36–S37. https://doi.org/10.1016/j.jdcr.2015.09.012
doi: 10.1016/j.jdcr.2015.09.012
pubmed: 27051807
pmcid: 4809584
Garrouste C, Anglicheau D, Kamar N et al (2016) Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: clinical outcomes. Medicine (Baltimore) 95(41):e5108. https://doi.org/10.1097/md.0000000000005108
doi: 10.1097/md.0000000000005108
pubmed: 27741127
De Simone C, Perino F, Caldarola G et al (2016) Treatment of psoriasis with etanercept in immunocompromised patients: two case reports. J Int Med Res 44(Suppl 1):67–71. https://doi.org/10.1177/0300060515593250
doi: 10.1177/0300060515593250
pubmed: 27683143
pmcid: 5536537
Cicora F, Roberti J (2016) Recurrent psoriasis after introduction of belatacept in 2 kidney transplant recipients. Prog Transplant 26(2):109–111. https://doi.org/10.1177/1526924816640674
doi: 10.1177/1526924816640674
pubmed: 27207397
Dedemadi G, Koukoulaki M, Vougas V et al (2018) Generalized pustular psoriasis (Von Zumbusch type) following renal transplant: a case report. Exp Clin Transplant 16(4):488–490. https://doi.org/10.6002/ect.2016.0036
doi: 10.6002/ect.2016.0036
pubmed: 27915962
Lora V, Graceffa D, De Felice C et al (2019) Treatment of severe psoriasis with ixekizumab in a liver transplant recipient with concomitant hepatitis B virus infection. Dermatol Ther 32(3):e12909. https://doi.org/10.1111/dth.12909
doi: 10.1111/dth.12909
pubmed: 30964590
García-Zamora E, Gómez de la Fuente E, Miñano-Medrano R, López-Estebaranz JL (2020) Use of etanercept for psoriasis in a renal transplant recipient. Actas Dermosifiliogr 111(2):169–171. https://doi.org/10.1016/j.ad.2018.07.013
doi: 10.1016/j.ad.2018.07.013
pubmed: 31627849
Di Altobrando A, Lacava R, Patrizi A et al (2020) Use of anti-IL 17A for psoriasis is not necessarily contraindicated in organ transplantation patients. Eur J Dermatol 30(3):311–313. https://doi.org/10.1684/ejd.2020.3776
doi: 10.1684/ejd.2020.3776
pubmed: 32540794
Singh I, Uy A, Kassardjian A, Armstrong AW (2021) Brodalumab in an organ transplant recipient with psoriasis. Cutis 107(2):104–106. https://doi.org/10.12788/cutis.0167
doi: 10.12788/cutis.0167
pubmed: 33891842